Security key
87978U207
Tempest Therapeutics, Inc. - Common Stock, par value $0.001 per share (TPST)
CUSIP: 87978U207
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 674,784
- Total 13F value
- $4,588,483
- Share change
- -2,833,041
- Put/Call ratio
- 1415%
- SEC-reported price per share
- $6.80
- Number of holders
- 17
- Value change
- +$1,995,038
- Number of buys
- 15
- Number of sells
- 2
- Shares outstanding
- 13,473,733
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
17
Top holders
10
TPST full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Previous quarter: Q1 2025
Tempest Therapeutics, Inc. SEC filings
Tempest Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 87978U207
Recent filing periods:
Ownership snapshot
Top reported holders of TPST - Tempest Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Versant Venture Managemen...
Disclosed value leader
Versant Venture Managemen...
Comparable rows
15/15
Latest evidence
31 Mar 2025
13F
Lead comparable stake: 26%
Showing 1-6 of 15 holder rows.
Quick read
Versant Venture Management, LLC leads the comparable SEC ownership view at 26%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Versant Venture Management, LLC's linked filing trail.
Comparable ownership
Top 5
Versant Venture Management, LLC
26%
BlackRock, Inc.
3.8%
GEODE CAPITAL MANAGEMENT, LLC
2.9%
FMR LLC
2.9%
UBS Group AG
2.2%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Versant Venture Management, LLC |
13F
Company
|
26%
|
$2,588,207
3,507,055 shares
|
— | 31 Mar 2025 |
| BlackRock, Inc. |
13F
Company
|
3.8%
|
$414,389
561,503 shares
|
— | 31 Mar 2025 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
2.9%
|
$319,827
433,346 shares
|
— | 31 Mar 2025 |
| FMR LLC |
13F
Company
|
2.9%
|
$318,766
431,932 shares
|
— | 31 Mar 2025 |
| UBS Group AG |
13F
Company
|
2.2%
|
$238,890
323,699 shares
|
— | 31 Mar 2025 |
| VANGUARD GROUP INC |
13F
Company
|
2%
|
$219,833
297,877 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
17
Shares
674,784
Rows available
17
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
2
Q2 2025 holders
17
Holder diff
15
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend